View more on these topics

Merrill Lynch looks at healthscience

Merrill Lynch Investment Managers has introduced the MST world healthscience fund.

Based in Luxemburg but managed from London and New York, the fund is a SICAV aimed at investors who are looking to add a specialist, high-risk investment to an existing portfolio. The fund is denominated in dollars.

MST world healthscience will invest in companies that are involved in healthcare, pharmaceuticals, biotechnology and medical technology. The bulk of the fund will invest in the US, with 15 per cent of the fund in Europe and the remaining five per cent investing in Japan.

New York-based fund manager Jordan Schreiber has been in charge of the Merrill Lynch healthcare fund since 1993.

Merrill Lynch believes that the market volatility of the past few months has bottomed out and that now is a good time to buy stocks while share prices remain low. However it is still uncertain if the present market volatility has ended and if stocks have bottomed out.

According to Standard & Poor’s the Merrill Lynch healthcare fund is ranked 3 out of 9 funds, based on £1,000 invested on a bid to bid basis with gross income reinvested over five years to April 2, 2001.



&#39Solid rise in house prices&#39

Continuing rises in house prices are creating a solid outlook for the rest of the year, according to March figures from Halifax and Nationwide. Halifax, the UK’ biggest lender, says the average property price rose by 0.4 per cent in March to £87,453 from February’ average of £87,088. Nationwide figures for March show a rise […]

Another fine mess

I note with some amazement that Legal & General propose to reimburse stakeholder policyholders with any charges arising in excess of the permitted 1 per cent a year cap – not least because this will be conditional upon the third party funds which may give rise to this outperforming lower charging funds. This raises a […]

Alliance Capital – ACM Bernstein Vallue Investments – European Value Portfolio

Tuesday, 10 April.Type: Ucits.Aim: Growth and income by investing in undervalued European companies.Minimum investment: $2,000 or Euros 2,000.Place of registration: Luxemburg.Investment split: 100 per cent in 70-90 undervalued European companies.Isa link: No.Charges: Initial – class A shares up to 6.25 per cent, annual 1.05 per cent.Commission: Initial 0.75 per cent.Tel: 020 7470 1588.

JPM gets smart with new fund

JP Morgan Fleming Asset Management has introduced the JPM Europe smart index fund.The fund is Luxembourg-based and is aimed at cautious investors who are looking to add a European fund to their existing portfolio. It is denominated in Euros.JPM Europe smart will partly track the MSCI Europe index, and will partly be managed by team […]

Harris Associates' view on the UK’s vote to leave the EU

By David Herro, Partner, Deputy Chairman, Portfolio Manager and Chief Investment Officer of International Equity at Harris Associates Britain’s vote to exit the European Union has led to significant uncertainty across global markets. We believe market impact of this uncertainty, though severe, is more of a shorter-term phenomenon which will provide an opportunity for long-term […]


News and expert analysis straight to your inbox

Sign up


    Leave a comment


    Why register with Money Marketing ?

    Providing trusted insight for professional advisers.  Since 1985 Money Marketing has helped promote and analyse the financial adviser community in the UK and continues to be the trusted industry brand for independent insight and advice.

    News & analysis delivered directly to your inbox
    Register today to receive our range of news alerts including daily and weekly briefings

    Money Marketing Events
    Be the first to hear about our industry leading conferences, awards, roundtables and more.

    Research and insight
    Take part in and see the results of Money Marketing's flagship investigations into industry trends.

    Have your say
    Only registered users can post comments. As the voice of the adviser community, our content generates robust debate. Sign up today and make your voice heard.

    Register now

    Having problems?

    Contact us on +44 (0)20 7292 3712

    Lines are open Monday to Friday 9:00am -5.00pm